Cargando…

MRI as a biomarker for breast cancer diagnosis and prognosis

Breast cancer (BC) is the most frequently diagnosed female invasive cancer in Western countries and the leading cause of cancer-related death worldwide. Nowadays, tumor heterogeneity is a well-known characteristic of BC, since it includes several nosological entities characterized by diﬀerent morpho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galati, Francesca, Rizzo, Veronica, Trimboli, Rubina Manuela, Kripa, Endi, Maroncelli, Roberto, Pediconi, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459861/ https://www.ncbi.nlm.nih.gov/pubmed/36105423 http://dx.doi.org/10.1259/bjro.20220002

Ejemplares similares

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
por: Moffa, Giuliana, et al.
Publicado: (2020)

Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI
por: Rizzo, Veronica, et al.
Publicado: (2021)

Special Issue “Advances in Breast MRI”
por: Galati, Francesca, et al.
Publicado: (2021)

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
por: Galati, Francesca, et al.
Publicado: (2022)

Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity
por: Kripa, Endi, et al.
Publicado: (2022)

Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense Breasts
por: Moffa, Giuliana, et al.
Publicado: (2023)

Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score(®) Test?
por: Galati, Francesca, et al.
Publicado: (2022)

Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM
por: Pediconi, Federica, et al.
Publicado: (2020)

Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge
por: Galati, Francesca, et al.
Publicado: (2023)

The potential of predictive and prognostic breast MRI (P2-bMRI)
por: Dietzel, Matthias, et al.
Publicado: (2022)

Visceral adipose tissue area predicts intensive care unit admission in COVID-19 patients
por: Pediconi, Federica, et al.
Publicado: (2021)

MRI versus Mammography plus Ultrasound in Women at Intermediate Breast Cancer Risk: Study Design and Protocol of the MRIB Multicenter, Randomized, Controlled Trial
por: Bonelli, Luigina Ada, et al.
Publicado: (2021)

Breast arterial calcifications as a biomarker of cardiovascular risk: radiologists’ awareness, reporting, and action. A survey among the EUSOBI members
por: Trimboli, Rubina Manuela, et al.
Publicado: (2020)

Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
por: Trimboli, Rubina Manuela, et al.
Publicado: (2020)

Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
por: Yang, Ruozhu, et al.
Publicado: (2022)

Clinical Breast MR Using MRS or DWI: Who Is the Winner?
por: Sardanelli, Francesco, et al.
Publicado: (2016)

(23)Na‐MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis
por: Poku, Linda Osei, et al.
Publicado: (2020)

Recommendations for breast imaging follow-up of women with a previous history of breast cancer: position paper from the Italian Group for Mammography Screening (GISMa) and the Italian College of Breast Radiologists (ICBR) by SIRM
por: Bucchi, Lauro, et al.
Publicado: (2016)

Imaging technologies in the differential diagnosis and follow-up of brown tumor in primary hyperparathyroidism: Case report and review of the literature
por: Diacinti, Davide, et al.
Publicado: (2020)

Potential of the Microbiome as a Biomarker for Early Diagnosis and Prognosis of Breast Cancer
por: Jarman, Robyn, et al.
Publicado: (2020)

New Biomarkers Based on Dendritic Cells for Breast Cancer Treatment and Prognosis Diagnosis
por: Zhao, Fanjia, et al.
Publicado: (2023)

Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis
por: Lee, Yujin, et al.
Publicado: (2023)

Detection and quantification of breast arterial calcifications on mammograms: a deep learning approach
por: Mobini, Nazanin, et al.
Publicado: (2023)

Editorial: Impact of Breast MRI on Breast Cancer Treatment and Prognosis
por: Bitencourt, Almir, et al.
Publicado: (2022)

Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy
por: Tinterri, Corrado, et al.
Publicado: (2022)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

Development and Validation of Ferroptosis-Related lncRNAs as Prognosis and Diagnosis Biomarkers for Breast Cancer
por: Yao, Zhi-Yong, et al.
Publicado: (2022)

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
por: Oh, Hyung-Hoon, et al.
Publicado: (2020)

Structured reporting of x-ray mammography in the first diagnosis of breast cancer: a Delphi consensus proposal
por: Neri, Emanuele, et al.
Publicado: (2022)

Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
por: Zhu, Qiu-Li, et al.
Publicado: (2010)

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
por: Bertoli, Gloria, et al.
Publicado: (2015)

Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies
por: Alam, Md. Shahin, et al.
Publicado: (2022)

The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker
por: Gao, Yang, et al.
Publicado: (2023)

Role of MRI in the diagnosis and prognosis of ventricular arrhythmias
por: Sharma, Nakul C, et al.
Publicado: (2011)

Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa)
por: Bernardi, Daniela, et al.
Publicado: (2017)

Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro
por: Lou, Weiyang, et al.
Publicado: (2020)

Diagnosis and grading of radiographic osteoporotic vertebral deformity by general radiologists after a brief self-learning period
por: Wáng, Yì Xiáng J., et al.
Publicado: (2020)

Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study
por: Liu, Nan, et al.
Publicado: (2022)

Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
por: Gianni, Caterina, et al.
Publicado: (2022)

Identification of biomarkers related to tumorigenesis and prognosis in breast cancer
por: Paizula, Xuelaiti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h9chdmlommq4dcbqm7tlqcc7b6